FIELD: biotechnology; medicine.
SUBSTANCE: disclosed is a composite material for a device for quantifying lactate content in physiological fluids, comprising polymer matrix (4), nanomaterial inclusions and lactate oxidase enzyme inclusions (3), immobilized in polymer matrix (4), wherein polymer matrix (4) contains a polymer modified with a redox-active compound. Polymer used is bovine serum albumin, the redox-active compound used is neutral red covalently bonded to said polymer, and the nanomaterial is single-wall carbon nanotubes (2). Also disclosed is a device for quantitative assessment of lactate content in physiological fluids.
EFFECT: group of inventions provides an increase in the upper limit of the range of determined concentrations of lactate in physiological fluids to 57 mM, as well as reduced time spent on a single measurement.
3 cl, 5 dwg, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
DEVICE FOR QUANTIFYING GLUCOSE CONTENT IN PHYSIOLOGICAL FLUIDS | 2024 |
|
RU2823523C1 |
APPARATUS FOR DETERMINING VOLATILE ALKYLPHENOLS IN AQUEOUS MEDIA | 2023 |
|
RU2816917C1 |
TISSUE ENGINEERING STRUCTURE FOR CARDIAC TISSUE REGENERATION | 2019 |
|
RU2725860C1 |
STRAIN-SENSITIVE SILICONE SENSOR AND METHOD OF ITS ATTACHMENT | 2022 |
|
RU2810692C1 |
METHOD FOR OBTAINING OF BIOCOMPATIBLE NANOMATERIAL | 2016 |
|
RU2633088C1 |
DEVICE FOR QUANTIFYING GLUCOSE CONTENT IN PHYSIOLOGICAL FLUIDS | 2024 |
|
RU2823521C1 |
ARTIFICIAL MUSCLE FOR HEART TISSUE | 2017 |
|
RU2675062C1 |
DEVICE FOR QUANTIFYING GLUCOSE CONTENT IN PHYSIOLOGICAL FLUIDS | 2024 |
|
RU2823524C1 |
BIPOLAR DEFORMATION SENSOR BASED ON BIOCOMPATIBLE NANOMATERIAL | 2017 |
|
RU2662060C1 |
METHOD OF PRODUCING NANOCOMPOSITE JOINT LIGAMENT IMPLANT | 2019 |
|
RU2744710C2 |
Authors
Dates
2025-02-24—Published
2024-06-11—Filed